The American Heart Association and the American College of Cardiology have introduced the first clinical practice guideline for cardiovascular-kidney-metabolic (CKM) syndrome, a framework designed to identify and manage the interconnected risks of heart, kidney, and metabolic diseases. Nearly 90% of U.S. adults possess at least one risk factor for the condition, such as obesity, high blood pressure, or abnormal blood sugar, according to the June 2026 guidelines published in the journals Circulation and JACC.
How is CKM Syndrome Staged?
Clinicians use a four-stage system to assess patient risk and determine appropriate medical interventions. According to the guidelines, this staging helps doctors move from prevention to treatment as disease progresses:
- Stage 1: Patients with excess weight or prediabetes, but no other metabolic or cardiovascular complications.
- Stage 2: Individuals with metabolic risk factors like high blood pressure, abnormal lipids, or chronic kidney disease, but without diagnosed cardiovascular disease.
- Stage 3: Patients with subclinical cardiovascular disease or high-risk chronic kidney disease, often identified through the PREVENT-CVD risk equations.
- Stage 4: Individuals with established cardiovascular disease, such as heart failure, coronary heart disease, or stroke, alongside metabolic or kidney risk factors.
Why Do Heart, Kidney, and Metabolic Health Overlap?
Medical consensus increasingly views these systems as a single, integrated network rather than separate organ functions. Dr. Chiadi E. Ndumele, chair of the guideline committee at Johns Hopkins School of Medicine, notes that these conditions do not occur in isolation. By treating the body as an interconnected system, clinicians can address the root causes of disease before a major cardiac event occurs.
This shift contrasts with older medical models that often treated hypertension, diabetes, and kidney dysfunction in silos. The new guidelines prioritize a holistic approach, recommending that doctors screen for social determinants of health—such as food insecurity or housing instability—which significantly impact a patient’s ability to maintain metabolic health.
Did you know?
Roughly 40% of U.S. adults and 21% of children and adolescents live with obesity, which acts as a primary driver for the development of CKM syndrome, according to data from the American Heart Association and the American College of Cardiology.
What Are the Latest Treatment Strategies?
The guideline emphasizes a combination of lifestyle modifications and targeted pharmacological therapy. For the first time, GLP-1-based medications are recommended for specific patients with obesity or Type 2 diabetes to reduce the risk of cardiovascular events.
According to Dr. Fátima Rodriguez of Stanford Medicine, the "Life’s Essential 8" framework remains the gold standard for prevention. This includes:
- Prioritizing regular physical activity.
- Maintaining a heart-healthy diet.
- Managing blood pressure, blood sugar, and cholesterol levels.
- Ensuring quality sleep and avoiding tobacco use.
In cases where lifestyle changes and medication are insufficient, the guidelines state that metabolic and bariatric surgery may be considered as a therapeutic option to manage CKM syndrome progression.
Frequently Asked Questions
What is the primary goal of the new CKM syndrome guidelines?
The goal is to identify cardiovascular, kidney, and metabolic risks earlier through a unified staging system, allowing for proactive, coordinated care to prevent severe organ damage.
How does the new PREVENT-CVD equation differ from older tools?
The PREVENT equations offer a more precise estimation of 10- and 30-year cardiovascular risk by explicitly incorporating kidney and metabolic health markers.
Are GLP-1 medications recommended for everyone with CKM syndrome?
No. These medications are recommended for select individuals who meet specific criteria regarding obesity, Type 2 diabetes, and cardiovascular risk factors.
How can I reduce my risk of developing CKM syndrome?
Adopting the American Heart Association’s "Life’s Essential 8" is the primary recommendation. This includes managing weight, blood pressure, and nutrition to protect heart, kidney, and metabolic function simultaneously.
Are you managing your cardiovascular health? Talk to your primary care physician about the new CKM staging guidelines and how your metabolic and kidney health might influence your long-term heart risk. Subscribe to our newsletter for more updates on the latest medical breakthroughs.